Owlstone Medical announces key study results on use of Breath Biopsy for improved detection of liver disease including NASH and NAFLD
Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure liver function and stage liver disease.
Source: news-medical.net